네오지노믹스(주)
DE ˙ DB ˙ US64049M2098
€8.62 ↑0.03 (0.35%)
2026-06-04
주가
SecurityDE:NG9 / NeoGenomics, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership18,861,974 shares
Ownership 14.60%
BlackRock, Inc. ownership in NG9 / NeoGenomics, Inc.

2025-10-17 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 18,861,974 shares of NeoGenomics, Inc. (DE:NG9). This represents 14.6 percent ownership of the company. In their previous filing dated 2024-01-22 , BlackRock, Inc. had reported owning 19,980,993 shares, indicating a decrease of -5.60 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2025-10-17 2025-10-17 13G/A 19,980,993 18,861,974 -5.60 14.60 -7.01
2024-01-22 2024-01-22 13G/A 21,932,623 19,980,993 -8.90 15.70 -9.77
2023-01-23 2023-01-23 13G/A 19,328,254 21,932,623 13.47 17.40 10.83
2022-01-27 2022-01-27 13G/A 19,328,254 19,328,254 0.00 15.70 0.00
2022-01-26 2022-01-26 13G 17,246,570 19,328,254 12.07 15.70 1.29
2021-01-25 2021-01-25 13G 15,589,132 17,246,570 10.63 15.50 4.03
2020-02-04 2020-02-04 13G/A 12,723,340 15,589,132 22.52 14.90 9.56
2019-02-11 2019-02-11 13G/A 5,519,647 12,723,340 130.51 13.60 130.51
2019-02-08 2019-02-08 13G 5,519,647 5,519,647 0.00 5.90 0.00
2019-02-07 2019-02-07 13G 5,519,647 5.90

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NEOGENOMICS COM NEW 64049M209 19,957,502 496,153 2.55 148,085 -35.30 0.0002
2026-02-12 2025-12-31 13F NEOGENOMICS COM NEW 64049M209 19,461,349 162,420 0.84 228,865 53.61 0.0039
2025-11-12 2025-09-30 13F NEOGENOMICS COM NEW 64049M209 19,298,929 -125,659 -0.65 148,988 4.93 0.0026
2025-08-12 2025-06-30 13F NEOGENOMICS COM NEW 64049M209 19,424,588 -439,838 -2.21 141,994 -24.68 0.0027
2025-05-02 2025-03-31 13F NEOGENOMICS COM NEW 64049M209 19,864,426 -379,241 -1.87 188,513 -43.49 0.0040
2025-02-07 2024-12-31 13F NEOGENOMICS COM NEW 64049M209 20,243,667 332,324 1.67 333,616 13.59 0.0068
2024-11-13 2024-09-30 13F NEOGENOMICS COM NEW 64049M209 19,911,343 241,269 1.23 293,692 7.65 0.0062
2024-08-13 2024-06-30 13F NEOGENOMICS COM NEW 64049M209 19,670,074 -180,790 -0.91 272,824 -12.57 0.0062
2024-05-10 2024-03-31 13F NEOGENOMICS COM NEW 64049M209 19,850,864 -130,129 -0.65 312,056 -3.48 0.0073
2024-02-13 2023-12-31 13F NEOGENOMICS COM NEW 64049M209 19,980,993 -121,915 -0.61 323,292 30.75 0.0082
2023-11-13 2023-09-30 13F NEOGENOMICS COM NEW 64049M209 20,102,908 -673,304 -3.24 247,266 -25.94 0.0071
2023-08-11 2023-06-30 13F NEOGENOMICS COM NEW 64049M209 20,776,212 -532,168 -2.50 333,874 -10.00 0.0092
2023-05-12 2023-03-31 13F NEOGENOMICS COM NEW 64049M209 21,308,380 -625,097 -2.85 370,979 83.05 0.0109
2023-02-13 2022-12-31 13F NEOGENOMICS COM NEW 64049M209 21,933,477 824,295 3.90 202,665 11.51 0.0064
2022-11-14 2022-09-30 13F NEOGENOMICS COM NEW 64049M209 21,109,182 79,055 0.38 181,750 6.04 0.0062
2022-08-12 2022-06-30 13F NEOGENOMICS COM NEW 64049M209 21,030,127 1,440,078 7.35 171,396 -27.99 0.0055
2022-05-12 2022-03-31 13F NEOGENOMICS COM NEW 64049M209 19,590,049 261,795 1.35 238,018 -63.91 0.0064
2022-02-10 2021-12-31 13F NEOGENOMICS COM NEW 64049M209 19,328,254 569,039 3.03 659,480 -27.13 0.0168
2021-11-09 2021-09-30 13F NEOGENOMICS COM NEW 64049M209 18,759,215 36,710 0.20 904,947 7.01 0.0253
2021-08-11 2021-06-30 13F NEOGENOMICS COM NEW 64049M209 18,722,505 -18,621 -0.10 845,695 -6.44 0.0235
2021-05-07 2021-03-31 13F NEOGENOMICS COM NEW 64049M209 18,741,126 1,494,556 8.67 903,886 -2.66 0.0266
2021-02-05 2020-12-31 13F NEOGENOMICS COM NEW 64049M209 17,246,570 861,490 5.26 928,557 53.62 0.0296
2020-11-06 2020-09-30 13F NEOGENOMICS COM NEW 64049M209 16,385,080 -291,155 -1.75 604,445 17.00 0.0223
2020-08-14 2020-06-30 13F NEOGENOMICS COM NEW 64049M209 16,676,235 1,364,731 8.91 516,629 22.21 0.0206
2020-05-01 2020-03-31 13F NEOGENOMICS COM NEW 64049M209 15,311,504 -277,628 -1.78 422,750 -7.29 0.0207
2020-02-13 2019-12-31 13F NEOGENOMICS COM NEW 64049M209 15,589,132 273,141 1.78 455,982 55.71 0.0175
2019-11-08 2019-09-30 13F NEOGENOMICS COM NEW 64049M209 15,315,991 390,664 2.62 292,842 -10.57 0.0123
2019-08-22 2019-06-30 13F/A-1 NEOGENOMICS COM NEW 64049M209 14,925,327 1,100,263 7.96 327,462 15.77 0.0140
2019-08-13 2019-06-30 13F NEOGENOMICS COM NEW 64049M209 14,925,327 1,100,263 327,462
2019-05-09 2019-03-31 13F NEOGENOMICS COM NEW 64049M209 13,825,064 8,305,417 150.47 282,861 306.39 0.0126
2019-02-08 2018-12-31 13F NEOGENOMICS COM NEW 64049M209 5,519,647 440,621 8.68 69,603 -10.72 0.0035
2018-11-09 2018-09-30 13F NEOGENOMICS COM NEW 64049M209 5,079,026 929,697 22.41 77,960 43.32 0.0034
2018-08-09 2018-06-30 13F NEOGENOMICS COM NEW 64049M209 4,149,329 184,386 4.65 54,397 68.13 0.0025
2018-05-09 2018-03-31 13F NEOGENOMICS COM NEW 64049M209 3,964,943 12,147 0.31 32,354 -7.62 0.0015
2018-02-09 2017-12-31 13F NEOGENOMICS COM NEW 64049M209 3,952,796 54,998 1.41 35,022 -19.27 0.0017
2017-11-14 2017-09-30 13F NEOGENOMICS COM NEW 64049M209 3,897,798 476,681 13.93 43,381 41.52 0.0022
2017-08-10 2017-06-30 13F NEOGENOMICS COM NEW 64049M209 3,421,117 90,861 2.73 30,653 16.66 0.0016
2017-05-12 2017-03-31 13F NEOGENOMICS COM NEW 64049M209 3,330,256 3,326,005 78,240.53 26,276 72,888.89 0.0014
2017-02-10 2016-12-31 13F NEOGENOMICS COM NEW 64049M209 4,251 -484 -10.22 36 -7.69 0.0001
2016-11-08 2016-09-30 13F NEOGENOMICS COM NEW 64049M209 4,735 317 7.18 39 11.43 0.0001
2016-08-10 2016-06-30 13F NEOGENOMICS COM NEW 64049M209 4,418 722 19.53 35 40.00 0.0001
2016-05-10 2016-03-31 13F NEOGENOMICS COM NEW 64049M209 3,696 2,272 159.55 25 127.27 0.0000
2016-02-11 2015-12-31 13F NEOGENOMICS COM NEW 64049M209 1,424 0 0.00 11 37.50 0.0000
2015-11-13 2015-09-30 13F NEOGENOMICS COM NEW 64049M209 1,424 0 0.00 8 0.00 0.0000
2015-08-07 2015-06-30 13F NEOGENOMICS COM NEW 64049M209 1,424 1,424 8 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.